| Literature DB >> 31911522 |
Jane N T Sattoe1, Mariëlle A C Peeters1,2, Jannie Haitsma1, AnneLoes van Staa3,2, Victorien M Wolters4, Johanna C Escher5.
Abstract
OBJECTIVE: Developing and evaluating effective transition interventions for young people (16-25 years) with inflammatory bowel disease (IBD) is a high priority. While transition clinics (TCs) have been recommended, little is known about their operating structures and outcomes. This study aimed to gain insight into the value of a TC compared with direct handover care.Entities:
Keywords: adolescents; inflammatory bowel disease; self-management; transitional care; young adults
Mesh:
Year: 2020 PMID: 31911522 PMCID: PMC6955474 DOI: 10.1136/bmjopen-2019-033535
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Quantitative data collection method, method description and outcome measures
| Method | Description | Themes addressed or outcome measures |
| Chart review | Of each outpatient department, all charts were reviewed of patients who transferred to adult care 2–4 years prior to data collection. Data from chart reviews were collected for four moments over time: second year before transfer (T1), year before transfer (T2), year after transfer (T3) and second year after transfer (T4). T3 and T4 data were only available for young people who transferred to an adult department within the same hospital. Patients with severe intellectual disabilities or known psychiatric problems were excluded. |
Whether young people had a |
| Survey | An invitation for a digital survey was sent to all patients whose charts were reviewed. |
Self-reported Perceived
|
Study response per data collection method per setting
| Data collection method | Transition clinic | Control setting |
| Semistructured interviews | 5 interviews: paediatric IBD nurse specialist | 3 interviews: paediatric gastroenterologist (n=1), adult care nurse (n=1) and adult gastroenterologist (n=1). |
| Observations | 3×4 hours of clinical consultations before transfer. | 2×4 hours of clinical consultations before transfer. |
| Chart reviews | n=56 (young people with IBD), of which 25 transferred to an adult department in another hospital. Number of charts per measurement moment were: T1, n=55; T2, n=56; T3, n=30; T4, n=30. | n=54 (young people with IBD), of which 30 transferred to an adult department in another hospital. Number of charts per measurement moment were: T1, n=44; T2, n=54; T3, n=24; T4, n=23. |
| Surveys | n=21 responded (37.5%); n=14 (25.0%) filled out the survey. | n=25 responded (46.3%); n=19 (35.2%) filled out the survey. |
IBD, inflammatory bowel disease.
Characteristics of the study samples of young people with IBD
| Transition clinic | Control setting | P value* | |
| Gender (male) | 31 (55.4%) | 30 (55.6%) | 0.983 |
| Age at the time of survey (years) | 20.89 (±0.908) | 21.02 (±0.961) | 0.482 |
| Diagnosis | |||
| Crohn’s disease | 29 (51.8%) | 24 (44.4%) | 0.701 |
| Ulcerative colitis | 24 (42.8%) | 23 (42.6%) | |
| IBD unclassified | 3 (5.4%) | 6 (11.1%) | |
| Ulcerative proctitis | – | 1 (1.9) | |
| Timing of diagnosis | |||
| Within 2 years before transfer | 2 (3.6%) | 11 (20.4%) | 0.006 |
| More than 2 years before transfer | 54 (96.4%) | 43 (79.6%) | |
| Age at transfer (years) | 17.46 (±0.503) | 17.26 (±0.589) | 0.052 |
*Independent samples t-test or Pearson χ2 test.
IBD, inflammatory bowel disease.
Differences in service structures and daily routines between the two settings
| Characteristics of care | TC setting | Control setting (direct handover care) |
| Setting | Adult gastroenterology department | Paediatric gastroenterology department |
| Team of professionals | Paediatric IBD nurse specialist (n=1), paediatric gastroenterologists (n=2), adult gastroenterologist (n=1) and one family counsellor working in paediatric care (n=1) | Paediatric gastroenterologist (n=1) |
| Visitors | Young people with IBD aged 16–18 years with or without their parents | Young people with IBD with or without their parents until age of 18 |
| Visits TC | Every 3 months | – |
| Follow-up after transfer within the same hospital | By an adult gastroenterologist, but not necessarily the one involved at the TC | By an adult gastroenterologist or IBD nurse |
| Structure of care before transfer |
Each clinic starts with 1-hour multidisciplinary team meeting of professionals, usually lead by the paediatric nurse specialist Consultation with paediatric gastroenterologist or paediatric nurse Consultation with adult gastroenterologist for selected young people who will soon transfer to adult care; all young people treated at the TC will see the adult care gastroenterologist at least once before actual transfer to adult care, and preferable once every year |
No multidisciplinary team or nurse involved Measurements of weight and length by a medical assistant Consultation with paediatric gastroenterologist |
| Topics discussed (content of care) |
|
|
IBD, inflammatory bowel disease; TC, transition clinic.
Clinical and healthcare use outcomes of young people with IBD
| Chart review results | TC | Control setting | Effect size* | P value† |
| No of charts reviewed‡ | ||||
| T1 | n=55 | n=44 | ||
| T2 | n=56 | n=54 | ||
| T3 | n=30 | n=24 | ||
| T4 | n=30 | n=23 | ||
| Active disease during transfer (yes)§ | 5 (9.1%) | 18 (34.0%) | – | 0.002 |
| Relapse in year before transfer (T2) (yes)§ | 13 (23.6%) | 27 (50.9%) | – | 0.003 |
| Relapse in year after transfer (T3) (yes)¶ | 2 (6.9%) | 6 (25.0%) | – | 0.067 |
| Use of aminosalicylates (yes) | ||||
| T1 | 22 (40.0%) | 17 (40.5%) | – | 0.962 |
| T2 | 23 (41.1%) | 21 (38.9%) | – | 0.815 |
| T3 | 8 (26.7%) | 5 (20.8%) | – | 0.618 |
| T4 | 9 (30.0%) | 5 (21.7%) | – | 0.499 |
| Use of corticosteroids (yes) | ||||
| T1 | 17 (30.9%) | 9 (21.4%) | – | 0.296 |
| T2 | 15 (26.8%) | 14 (25.9%) | – | 0.919 |
| T3 | 9 (30.0%) | 4 (16.7%) | – | 0.255 |
| T4 | 10 (33.3%) | 1 (4.3%) | – | 0.010 |
| Use of immunomodulators (yes) | ||||
| T1 | 40 (72.7%) | 22 (52.4%) | – | 0.039 |
| T2 | 43 (76.8%) | 31 (57.4%) | – | 0.030 |
| T3 | 23 (76.7%) | 13 (54.2%) | – | 0.081 |
| T4 | 25 (83.3%) | 11 (47.8%) | – | 0.006 |
| Use of biologics/biosimilars (yes) | ||||
| T1 | 4 (7.3%) | 12 (28.6%) | – | 0.005 |
| T2 | 5 (8.9%) | 20 (37.0%) | – | 0.000 |
| T3 | 2 (6.7%) | 12 (50.0%) | – | 0.000 |
| T4 | 3 (10.0%) | 11 (47.8%) | – | 0.002 |
| No of planned consultations per year | ||||
| T1 | 3.33 (±1.75) | 3.34 (±2.07) | −0.01 | 0.972 |
| T2 | 4.71 (±2.08) | 3.74 (±2.03) | 0.47 | 0.015 |
| T3 | 2.43 (±1.14) | 2.71 (±1.12) | −0.25 | 0.378 |
| T4 | 2.23 (±1.50) | 1.96 (±1.26) | 0.18 | 0.480 |
| No of missed consultations per year | ||||
| T1 | 0.07 (±0.262) | 0.07 (±0.334) | 0 | 0.940 |
| T2 | 0.20 (±0.519) | 0.17 (±0.466) | 0.06 | 0.753 |
| T3 | 0.03 (±0.183) | 0.13 (±0.338) | −0.30 | 0.208 |
| T4 | 0.07 (±0.254) | 0.35 (±0.647) | −0.43 | 0.034 |
| No of unplanned hospital admissions per year | ||||
| T1 | 0.30 (±0.836) | 0.43 (±0.846) | −0.15 | 0.472 |
| T2 | 0.21 (±0.624) | 0.41 (±0.858) | −0.32 | 0.179 |
| T3 | 0 | 0.29 (±0.859) | −0.33 | 0.068 |
| T4 | 0.17 (±0.461) | 0 | 0.37 | 0.090 |
| No of emergency department visits per year | ||||
| T1 | 0.24 (±0.838) | 0.02 (±0.151) | 0.26 | 0.099 |
| T2 | 0.14 (±0.483) | 0.02 (±0.136) | 0.25 | 0.071 |
| T3 | 0.03 (±0.183) | 0.25 (±0.847) | 0.26 | 0.178 |
| T4 | 0 | 0 | – | – |
| Department to which young person transferred is recorded/known (yes) | 55 (98.2%) | 48 (88.9%) | – | 0.045 |
*Cohen’s d (based on largest SD).
†Independent samples t-test or Pearson χ2 test.
‡Second year before transfer=T1, year before transfer=T2, year after transfer=T3, second year after transfer=T4.
§Control setting n=53, TC setting n=55.
¶TC setting n=29.
IBD, inflammatory bowel disease; TC, transition clinic.
Self-reported healthcare-related and self-management outcomes of young people with IBD
| TC (n=14) | Direct handover care (n=19) | Effect size* | P value† | |
| Healthcare related | ||||
| Transfer experiences | 67.79 (±12.86) | 62.95 (±8.44) | 0.38 | 0.201 |
| Satisfaction with transition | 7.43 (±1.34) | 6.89 (±1.20) | 0.40 | 0.238 |
| Patient centredness | 16.64 (±3.46) | 16.26 (±3.31) | 0.11 | 0.751 |
| Self-management | ||||
| Self-management | 81.64 (±10.26) | 78.79 (±10.81) | 0.26 | 0.450 |
| Independence during consultations | 8.43 (±1.60) | 8.53 (±1.02) | −0.06 | 0.832 |
| Self-efficacy | 55.93 (±6.92) | 54.37 (±8.13) | 0.19 | 0.567 |
| Adherence to treatment‡ | 22.33 (±3.45) | 21.18 (±3.54) | 0.32 | 0.389 |
| Health-related quality of life§ | 78.34 (±23.87) | 77.67 (±15.43) | 0.03 | 0.923 |
*Cohen’s d (based on largest SD).
†Independent samples t-test.
‡TC group: n=12; direct handover care group: n=17.
§Direct handover care group: n=18.
IBD, inflammatory bowel disease; TC, transition clinic.